FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383745417> ?p ?o ?g. }

• W4383745417 abstract "Background Most thyroid cancers of follicular origin have a favorable outcome. Only a small percentage of patients will develop metastatic disease, some of which will become radioiodine refractory (RAI-R). Important challenges to ensure the best therapeutic outcomes include proper, timely, and appropriate diagnosis; decisions on local, systemic treatments; management of side effects of therapies; and a good relationship between the specialist, patients, and caregivers. Methods With the aim of providing suggestions that can be useful in everyday practice, a multidisciplinary group of experts organized the following document, based on their shared clinical experience with patients with RAI-R differentiated thyroid cancer (DTC) undergoing treatment with lenvatinib. The main areas covered are patient selection, initiation of therapy, follow-up, and management of adverse events. Conclusions It is essential to provide guidance for the management of RAI-R DTC patients with systemic therapies, and especially lenvatinib, since compliance and adherence to treatment are fundamental to achieve the best outcomes. While the therapeutic landscape in RAI-R DTC is evolving, with new targeted therapies, immunotherapy, etc., lenvatinib is expected to remain a first-line treatment and mainstay of therapy for several years in the vast majority of patients and settings. The guidance herein covers baseline work-up and initiation of systemic therapy, relevance of symptoms, multidisciplinary assessment, and patient education. Practical information based on expert experience is also given for the starting dose of lenvatinib, follow-up and monitoring, as well as the management of adverse events and discontinuation and reinitiating of therapy. The importance of patient engagement is also stressed." @default.
• W4383745417 created "2023-07-11" @default.
• W4383745417 creator A5014239599 @default.
• W4383745417 creator A5020492229 @default.
• W4383745417 creator A5023137678 @default.
• W4383745417 creator A5028801087 @default.
• W4383745417 creator A5032324073 @default.
• W4383745417 creator A5049341838 @default.
• W4383745417 creator A5055086811 @default.
• W4383745417 creator A5059107350 @default.
• W4383745417 creator A5061789223 @default.
• W4383745417 creator A5070621348 @default.
• W4383745417 creator A5081409867 @default.
• W4383745417 creator A5083660817 @default.
• W4383745417 date "2023-07-10" @default.
• W4383745417 modified "2023-10-18" @default.
• W4383745417 title "Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practice" @default.
• W4383745417 cites W1848939527 @default.
• W4383745417 cites W1967792499 @default.
• W4383745417 cites W1993169170 @default.
• W4383745417 cites W1999966467 @default.
• W4383745417 cites W2019607817 @default.
• W4383745417 cites W2040642592 @default.
• W4383745417 cites W2079353352 @default.
• W4383745417 cites W2100623280 @default.
• W4383745417 cites W2145150141 @default.
• W4383745417 cites W2183880308 @default.
• W4383745417 cites W2279540174 @default.
• W4383745417 cites W2589693271 @default.
• W4383745417 cites W2590945636 @default.
• W4383745417 cites W2626124580 @default.
• W4383745417 cites W2755672614 @default.
• W4383745417 cites W2797674032 @default.
• W4383745417 cites W2898012942 @default.
• W4383745417 cites W2901553335 @default.
• W4383745417 cites W2905726151 @default.
• W4383745417 cites W2944413955 @default.
• W4383745417 cites W2953846559 @default.
• W4383745417 cites W2975387808 @default.
• W4383745417 cites W2976988657 @default.
• W4383745417 cites W2980520209 @default.
• W4383745417 cites W2996441645 @default.
• W4383745417 cites W3100285555 @default.
• W4383745417 cites W3125149538 @default.
• W4383745417 cites W3150628717 @default.
• W4383745417 cites W3161172313 @default.
• W4383745417 cites W3201658013 @default.
• W4383745417 cites W3205347106 @default.
• W4383745417 cites W3205433234 @default.
• W4383745417 cites W4211213741 @default.
• W4383745417 cites W4221108892 @default.
• W4383745417 cites W4221130624 @default.
• W4383745417 cites W4280569805 @default.
• W4383745417 cites W4296095783 @default.
• W4383745417 cites W4310706560 @default.
• W4383745417 doi "https://doi.org/10.1530/etj-23-0068" @default.
• W4383745417 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37429326" @default.
• W4383745417 hasPublicationYear "2023" @default.
• W4383745417 type Work @default.
• W4383745417 citedByCount "0" @default.
• W4383745417 crossrefType "journal-article" @default.
• W4383745417 hasAuthorship W4383745417A5014239599 @default.
• W4383745417 hasAuthorship W4383745417A5020492229 @default.
• W4383745417 hasAuthorship W4383745417A5023137678 @default.
• W4383745417 hasAuthorship W4383745417A5028801087 @default.
• W4383745417 hasAuthorship W4383745417A5032324073 @default.
• W4383745417 hasAuthorship W4383745417A5049341838 @default.
• W4383745417 hasAuthorship W4383745417A5055086811 @default.
• W4383745417 hasAuthorship W4383745417A5059107350 @default.
• W4383745417 hasAuthorship W4383745417A5061789223 @default.
• W4383745417 hasAuthorship W4383745417A5070621348 @default.
• W4383745417 hasAuthorship W4383745417A5081409867 @default.
• W4383745417 hasAuthorship W4383745417A5083660817 @default.
• W4383745417 hasBestOaLocation W43837454171 @default.
• W4383745417 hasConcept C121332964 @default.
• W4383745417 hasConcept C121608353 @default.
• W4383745417 hasConcept C126322002 @default.
• W4383745417 hasConcept C142424586 @default.
• W4383745417 hasConcept C143998085 @default.
• W4383745417 hasConcept C144024400 @default.
• W4383745417 hasConcept C177713679 @default.
• W4383745417 hasConcept C185926286 @default.
• W4383745417 hasConcept C197934379 @default.
• W4383745417 hasConcept C22467394 @default.
• W4383745417 hasConcept C2776264508 @default.
• W4383745417 hasConcept C2778715236 @default.
• W4383745417 hasConcept C2779761222 @default.
• W4383745417 hasConcept C36289849 @default.
• W4383745417 hasConcept C530470458 @default.
• W4383745417 hasConcept C71924100 @default.
• W4383745417 hasConcept C87355193 @default.
• W4383745417 hasConceptScore W4383745417C121332964 @default.
• W4383745417 hasConceptScore W4383745417C121608353 @default.
• W4383745417 hasConceptScore W4383745417C126322002 @default.
• W4383745417 hasConceptScore W4383745417C142424586 @default.
• W4383745417 hasConceptScore W4383745417C143998085 @default.
• W4383745417 hasConceptScore W4383745417C144024400 @default.
• W4383745417 hasConceptScore W4383745417C177713679 @default.
• W4383745417 hasConceptScore W4383745417C185926286 @default.
• W4383745417 hasConceptScore W4383745417C197934379 @default.

• next